Consensus Ocular Therapeutix, Inc.

Equities

OCUL

US67576A1007

Market Closed - Nasdaq Other stock markets 21:00:00 09/05/2024 BST			5-day change	1st Jan Change
5.84 ^USD	+1.57%		-0.51%	+30.94%

05-07	Earnings Flash (OCUL) OCULAR THERAPEUTIX Posts Q1 Revenue $14.8M, vs. Street Est of $15.4M	MT
05-07	Ocular Therapeutix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Evolution of the average Target Price on Ocular Therapeutix, Inc.

Price target over the last 5 years

History of analyst recommendation changes

eeda.g6wHFEg74dAtn9V9mI8T1bHZpq4wsgMTZ1A439Sag1g.setGTixL0eZG87s4-8xympyh9shKh1p3EgYMiYP1wg_XyWVBB0iou3zqkA~289e2b8e98fa99a5b57e0f141b67f6fa

Analyst Recommendations on Ocular Therapeutix, Inc.

HC Wainwright Adjusts Price Target on Ocular Therapeutix to $15 From $12, Keeps Buy Rating	03-13	MT
TD Cowen Adjusts Price Target on Ocular Therapeutix to $11 From $8, Maintains Market Perform Rating	03-12	MT
JMP Securities Adjusts Ocular Therapeutix's Price Target to $24 From $12, Maintains Market Outperform Rating	03-12	MT
Piper Sandler Adjusts Ocular Therapeutix Price Target to $15 From $10, Maintains Overweight Rating	02-26	MT
HC Wainwright Adjusts Ocular Therapeutix Price Target to $12 From $10, Maintains Buy Rating	13/06/23	MT
HC Wainwright Adjusts Price Target on Ocular Therapeutix to $10 From $11, Maintains Buy Rating	09/05/23	MT
JMP Securities Adjusts Price Target on Ocular Therapeutix to $12 From $11, Keeps Market Outperform Rating	09/05/23	MT
Baird Initiates Ocular Therapeutix at Outperform With $18 Price Target	21/04/23	MT
JMP Securities Adjusts Price Target on Ocular Therapeutix to $11 From $12, Maintains Market Outperform Rating	07/03/23	MT
HC Wainwright Adjusts Price Target on Ocular Therapeutix to $11 From $9, Maintains Buy Rating	14/02/23	MT
JMP Securities Adjusts Price Target on Ocular Therapeutix's to $12 From $25, Maintains Market Outperform Rating	09/01/23	MT
Raymond James Adjusts Price Target on Ocular Therapeutix to $14 From $29, Maintains Strong Buy Rating	08/11/22	MT
HC Wainwright Trims Price Target on Ocular Therapeutix to $9 From $10, Maintains Buy Rating	08/11/22	MT
Berenberg Bank Assumes Coverage on Ocular Therapeutix With Buy Rating, $15 Price Target	10/08/22	MT
JMP Securities Adjusts Ocular Therapeutix Price Target to $25 From $20, Maintains Market Outperform Rating	09/08/22	MT
Jefferies Raises Price Target for Ocular Therapeutix to $6.50 From $5, Maintains Buy Rating	09/08/22	MT
Berenberg Bank Suspends Coverage of 25 Companies in Consumer Discretionary, Healthcare, Industrial Tech, and Software Sectors	01/07/22	MT
Piper Sandler Adjusts Price Target on Ocular Therapeutix to $10 From $16, Reiterates Overweight Rating	31/05/22	MT
Berenberg Bank Cuts Price Target on Ocular Therapeutix to $21 From $23, Maintains Buy Rating	11/05/22	MT
HC Wainwright Adjusts Price Target on Ocular Therapeutix to $10 From $14, Reiterates Buy Rating	10/05/22	MT
Piper Sandler Adjusts Price Target on Ocular Therapeutix to $16 From $20, Reiterates Overweight Rating	10/05/22	MT
JMP Securities Adjusts Ocular Therapeutix's Price Target to $22 from $30, Keeps Market Outperform Rating	01/03/22	MT
Berenberg Bank Adjusts Price Target on Ocular Therapeutix to $23 From $26, Maintains Buy Rating	10/11/21	MT
JMP Securities Adjusts Price Target on Ocular Therapeutix to $30 From $27, Maintains Market Outperform Rating	09/11/21	MT
OCULAR THERAPEUTIX : Piper Sandler Adjusts Price Target on Ocular Therapeutix to $20 From $27, Maintains Overweight Rating	25/10/21	MT